Improving Timely Administration of Essential Outpatient Medications in a Pediatric ED.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
06 Sep 2024
Historique:
received: 18 10 2023
revised: 22 05 2024
accepted: 12 06 2024
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 6 9 2024
Statut: aheadofprint

Résumé

The complexity of pediatric patients' outpatient medication regimens is increasing, and risk for medication errors is compounded in a busy emergency department (ED). As ED length of stay (LOS) increases, timely and accurate administration of essential outpatient medications has become increasingly challenging. Our objective was to increase the frequency of ordering of essential outpatient medications for patients with ED LOS >4 hours from 56% to 80% by June 2023. We conducted a quality improvement (QI) initiative in a pediatric ED with ∼60 000 annual visits comprising a total of 91 000 annual medication orders. We defined essential outpatient medications as antiepileptic drugs, cardiovascular medications, and immunosuppressants. Our QI interventions included a combination of electronic health record interventions, a triage notification system to identify patients with essential outpatient medications, and widespread educational interventions including trainee orientation and individualized nursing education. The primary outcome measure was percentage of essential outpatient medications ordered among patients with an ED LOS >4 hours, with a secondary measure of outpatient medication safety events. Baseline monthly ordering rate of selected medications for patients with an ED LOS >4 hours was 54%, with an increase to 66% over the study period. Refining our population yielded a rate of 81%. Outpatient medication safety events remained unchanged, with an average of 952 ED encounters between events. A multidisciplinary QI initiative led to increased essential outpatient medication ordering for patients in a pediatric ED with no change in safety events.

Sections du résumé

BACKGROUND AND OBJECTIVES UNASSIGNED
The complexity of pediatric patients' outpatient medication regimens is increasing, and risk for medication errors is compounded in a busy emergency department (ED). As ED length of stay (LOS) increases, timely and accurate administration of essential outpatient medications has become increasingly challenging. Our objective was to increase the frequency of ordering of essential outpatient medications for patients with ED LOS >4 hours from 56% to 80% by June 2023.
METHODS UNASSIGNED
We conducted a quality improvement (QI) initiative in a pediatric ED with ∼60 000 annual visits comprising a total of 91 000 annual medication orders. We defined essential outpatient medications as antiepileptic drugs, cardiovascular medications, and immunosuppressants. Our QI interventions included a combination of electronic health record interventions, a triage notification system to identify patients with essential outpatient medications, and widespread educational interventions including trainee orientation and individualized nursing education. The primary outcome measure was percentage of essential outpatient medications ordered among patients with an ED LOS >4 hours, with a secondary measure of outpatient medication safety events.
RESULTS UNASSIGNED
Baseline monthly ordering rate of selected medications for patients with an ED LOS >4 hours was 54%, with an increase to 66% over the study period. Refining our population yielded a rate of 81%. Outpatient medication safety events remained unchanged, with an average of 952 ED encounters between events.
CONCLUSIONS UNASSIGNED
A multidisciplinary QI initiative led to increased essential outpatient medication ordering for patients in a pediatric ED with no change in safety events.

Identifiants

pubmed: 39238471
pii: 199321
doi: 10.1542/peds.2023-064580
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this article to disclose.

Auteurs

Jessica K Creedon (JK)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Michelle Marini (M)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Kim Erdner (K)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Megan Trexler (M)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Megan Gerling (M)

Quality Department of Colorado Department of Public Health, Denver, Colorado.

John J Porter (JJ)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Caitlin Kent (C)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Andrew Capraro (A)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Diana Volpe (D)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Dhara Shah (D)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Niloufar Paydar-Darian (N)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Catherine Perron (C)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Anne Stack (A)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Joel D Hudgins (JD)

Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Boston; and.

Classifications MeSH